RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals why can't Oncy break through $2 on the NAS
ask your shorting friends.
not, even a week ago , they were touting under $1 , blah blah blah.
even some half Witt still on the other board yammering about ATM etc etc.
A few of my friends who bought last few weeks are quite happy with their 38% increase.
If they sell or not? Certainly not my concern.
The long game, will continue to play out.
the SP will go up & will go down.
However & this is what some are missing....
The comercial value of Pela & eventual value of Onc, has zero relevance to its trading SP.
should Roche see a 5x increase of tecentriq sales as a result of adding Pela...that determines the value of Pela & ONC.
Those shorting, today & no doubt there are, will get caught in a squeeze of a lifetime.
Onc is very thinly traded & subject to large % swings , both up & down.
The abstract further details will be realeased tomorrow @ a presentation in Boston.
The follow up on Monday. Will have a very wide audience.
could Onc be worth $3-$8billion on a take out?
That I do not know. I do know, the recent results scream for a phase 3 partner.
That deal will have $$$ attached to it , & will move tye SP, accordingly.
even a bargain basement price of $1billion, is $15ps.
so, relax, wait for the games to play out.
I'm not buying anymore, because I already did 2weeks ago.
certianky not selling.
presently the upside is unimaginable.
the downside?
not worth a short sale.
but if so inclined , please do.
I love watching a short squeeze.
Dont believe me, check out Dec 2019.
went from under $1 ( CDN) to a brief peak , over $6 ....in about 3 weeks.
short away!